organ transplantation	is a	medical procedure
organ transplantation	treats	organ failure
organ transplantation	relies on	donor matching
organ transplantation	requires	immunosuppression
organ transplantation	aims for	graft survival
deceased donor	provides	donor organ
living donor	provides	donor organ
donor organ	is allocated by	allocation system
recipient	receives	donor organ
graft	is a	transplanted organ component
ischemia time	influences	graft viability
cold ischemia time	influences	graft viability
warm ischemia time	influences	graft viability
HLA matching	predicts	graft survival
blood type compatibility	influences	donor selection
donor age	impacts	graft survival
recipient age	impacts	posttransplant outcomes
organ transplantation	requires	surgical expertise
organ procurement	facilitates	donor organ availability
organ preservation solution	maintains	donor organ viability
crossmatch	prevents	hyperacute rejection
panel reactive antibodies	complicates	donor selection
desensitization	enables	crossmatch success
immunosuppression	reduces	acute rejection
calcineurin inhibitors	include	tacrolimus
tacrolimus	is a	calcineurin inhibitor
cyclosporine	is a	calcineurin inhibitor
mycophenolate	is an	antiproliferative agent
sirolimus	is a	mTOR inhibitor
prednisone	is a	corticosteroid
steroid-sparing regimen	reduces	adverse effects
antimicrobial prophylaxis	prevents	infection
posttransplant period	monitoring	recipients
biopsy	evaluates	rejection
rejection	is a	complication
acute rejection	is a	complication
graft failure	results in	dialysis requirement
infection	risk	posttransplant period
malignancy	risk	long-term immunosuppression
cardiovascular disease	risk	posttransplant recipients
PTLD	risk	posttransplant immunosuppression
acute rejection	is a	complication
graft monitoring	enables	rejection detection
biomarker	predicts	rejection
creatinine	indicates	graft function
organ transplantation	increases	patient lifespan
waitlist	determines	donor availability
allocation system	governs	organ distribution
urgency score	influences	organ distribution
donor age	affects	organ quality
recipient comorbidity	influences	posttransplant outcome
drug interactions	affect	immunosuppressants
tacrolimus trough level	correlates with	toxicity
antibiotic prophylaxis	reduces	bacterial infection
fungal prophylaxis	reduces	fungal infection
nephrotoxicity	associated with	calcineurin inhibitors
vascular complications	increase	posttransplant mortality
cardiac allograft vasculopathy	causes	heart transplant failure
lung transplantation	requires	donor lung availability
pancreas transplantation	improves	glycemic control
liver transplant	treats	hepatic failure
kidney transplantation	treats	end-stage renal disease
liver transplantation	requires	hepatic allocation
heart transplantation	treats	end-stage heart failure
acute rejection	requires	prompt treatment
chronic rejection	leads to	graft dysfunction
immunosuppressive therapy	aims for	prevention of rejection
biopsy	confirms	rejection
donor tissue	is matched by	HLA typing
donor kidney	is allocated by	organ sharing network
kidney	is a	commonly transplanted organ
liver	is a	commonly transplanted organ
heart	is a	commonly transplanted organ
lung	is a	commonly transplanted organ
pancreas	is a	transplanted organ
intestine	is a	transplanted organ
organ shortage	presents	waiting times
waitlist mortality	remains	a concern
donor organ procurement	reduces	cold ischemia
organ preservation technique	extends	organ viability
hypothermic perfusion	improves	donor organ preservation
normothermic perfusion	preserves	graft viability
desensitization	enables	crossmatch success
crossmatch	screens for	donor antibodies
panel reactive antibodies	indicate	sensitization
sensitization	increases	crossmatch failure
organ allocation policy	shapes	transplant equity
transplant center	reports	graft outcomes
graft outcomes	correlate with	recipient comorbidity
body mass index	associates with	posttransplant complications
smoking history	influences	posttransplant outcomes
diabetes mellitus	impacts	transplant outcome
hypertension	accompanies	posttransplant care
nephrotoxicity	results from	calcineurin inhibitors
lipid abnormalities	occur with	immunosuppressants
malignancy risk	increases with	immunosuppression duration
vaccination status	influences	infection risk
posttransplant rehabilitation	improves	functional status
organ transplantation	used for	end-stage organ disease
